Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration
Author(s) -
Bekir Küçük,
Sibel Kadayıfçılar,
Bora Eldem
Publication year - 2018
Publication title -
international journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.634
H-Index - 29
eISSN - 2227-4898
pISSN - 2222-3959
DOI - 10.18240/ijo.2018.04.18
Subject(s) - medicine , macular degeneration , ranibizumab , visual acuity , ophthalmology , retrospective cohort study , pro re nata , surgery , bevacizumab , chemotherapy
To investigate the long-term visual and anatomical outcomes of patients who underwent intravitreal ranibizumab monotherapy to treat neovascular age-related macular degeneration (AMD) and followed-up for at least 2y.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom